Trinity Biotech
TRIB
#10829
Rank
NZ$13.32 M
Marketcap
NZ$19.74
Share price
-9.02%
Change (1 day)
1,592.90%
Change (1 year)

P/S ratio for Trinity Biotech (TRIB)

P/S ratio at the end of 2025: 0.3175

According to Trinity Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.1097. At the end of 2025 the company had a P/S ratio of 0.3175.

P/S ratio history for Trinity Biotech from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20250.3175-11.43%
20240.358524.3%
20230.2884-52.2%
20220.603463.83%
20210.3683-52.83%
20200.7809226.95%
20190.2388-51.58%
20180.4933-54.18%
20171.08-32.92%
20161.61-42.92%
20152.81-28.56%
20143.94-38.56%
20136.4163.51%
20123.9241.29%
20112.7733.09%
20102.08210.58%
20090.6710216.41%
20080.2121-76.29%
20070.8945-33.32%
20061.346.7%
20051.26144.46%
20040.5143-47.21%
20030.9741272%
20020.2619-35.67%
20010.4071

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Abbott Laboratories
ABT
4.08 3,076.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
4.71 3,571.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
5.56 4,237.34%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
0.4283 233.83%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
2.42 1,787.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Chembio Diagnostics
CEMI
0.3457 169.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
3.36 2,516.16%๐Ÿ‡บ๐Ÿ‡ธ USA